Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
  1. 4 Open-market sale Director sold 664 shares at $61.13 ($40,590)
  2. 4 Planned sale Chief Financial Officer sold 2,031 shares at $59.00 ($119,829)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Chief Financial Officer sold 2,000 shares at $57.50 ($115,000)
  6. 4 Planned sale Chief Executive Officer sold 34,800 shares at an average $55.33 ($1,925,525)
  7. 4 Planned sale Chief Executive Officer sold 5,200 shares at $55.09 ($286,454)
  8. 4 Exercise or conversion Chief Medical Officer acquired 32,070 shares (option exercise)
  9. 4 Planned sale Chief Financial Officer sold 2,000 shares at $52.26 ($104,519)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Planned sale Chief Medical Officer sold 2,996 shares at $50.00 ($149,800)
  18. 4 Planned sale Chief Medical Officer sold 6,677 shares at $50.04 ($334,128)
  19. 4 Planned sale Chief Medical Officer sold 2,100 shares at $50.17 ($105,367)
  20. 4 Exercise or conversion Chief Executive Officer acquired 7,000 shares (option exercise)

Page 4 of 15 · 283 filings